AvoMD has filed a notice of an exempt offering of securities to raise $8,147,449.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, AvoMD is raising $8,147,449.00 in new funding. Sources indicate that as part of senior management Chief Operating Officer, Laurence Coman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About AvoMD
AvoMD is a platform that translates clinical evidence – guidelines, pathways, and more – into the workflow at the point of care, available in the EHR or as a standalone web/mobile application. AvoMD instantly digitizes and optimizes the latest clinical evidence for point-of-care usage and adoption. AvoMD’s tools facilitate increased utilization of clinical pathways and other critical information needed in real-time. Available with or without EHR integration. A compliant solution for your HCPs to integrate pathways into the workflow. AvoMD provides ROI across crucial quality, workflow, and financial dimensions. Clinical practice is complicated. We’re bridging the gap between evidence and practice with better clinical decision support.
To learn more about AvoMD, visit http://www.avomd.io/
Contact:
Laurence Coman, Chief Operating Officer
631-786-3867
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.